The two large Se supplementation trials (the Selenium and Vitamin E Cancer Trial (SELECT) [28] and the Nutritional Prevention of Cancer (NPC) trial [29]) were conducted in the U.S., where 52% of the population take dietary supplements and have sufficient Se concentrations that could result in maximal selenoprotein activities or concentrations at baseline [30]. Here, SELENOS is linked to cancer.